This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Elongation factor 2 (EF-2)P13639Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Exosomes with immune modulatory features are present in human breast milk.
J Immunol. 2007 Aug 1;179(3):1969-78.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Characterization of PKD protein-positive exosome-like vesicles.
J Am Soc Nephrol. 2009 Feb;20(2):278-88. doi: 10.1681/ASN.2008060564. Epub 2009 Jan 21.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures.
Blood. 2009 Jul 16;114(3):723-32. doi: 10.1182/blood-2009-02-205930. Epub 2009 Apr 15.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes.
J Cell Physiol. 2009 Oct;221(1):221-31. doi: 10.1002/jcp.21847.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes.
J Cell Physiol. 2009 Oct;221(1):221-31. doi: 10.1002/jcp.21847.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells.
Mol Cell Proteomics. 2009 Oct;8(10):2201-11. doi: 10.1074/mcp.M900203-MCP200. Epub 2009 Jun 29.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature.
Mol Cell Proteomics. 2010 Feb;9(2):197-208. doi: 10.1074/mcp.M900152-MCP200. Epub 2009 Oct 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature.
Mol Cell Proteomics. 2010 Feb;9(2):197-208. doi: 10.1074/mcp.M900152-MCP200. Epub 2009 Oct 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques.
Circ Cardiovasc Genet. 2009 Aug;2(4):379-88. doi: 10.1161/CIRCGENETICS.108.842849. Epub 2009 May 14.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomics analysis of bladder cancer exosomes.
Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
Immunol Cell Biol. 2010 Nov-Dec;88(8):851-6. doi: 10.1038/icb.2010.64. Epub 2010 May 11.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Protein profile of exosomes from trabecular meshwork cells.
J Proteomics. 2011 May 16;74(6):796-804. doi: 10.1016/j.jprot.2011.02.024. Epub 2011 Mar 8.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic characterization of biogenesis and functions of matrix vesicles released from mineralizing human osteoblast-like cells.
J Proteomics. 2011 Jun 10;74(7):1123-34. doi: 10.1016/j.jprot.2011.04.005. Epub 2011 Apr 15.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways.
Mol Cell Proteomics. 2012 Feb;11(2):M111.012245. doi: 10.1074/mcp.M111.012245. Epub 2011 Oct 26.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.
J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3.
Mol Cell Proteomics. 2012 Jul;11(7):M111.012914. doi: 10.1074/mcp.M111.012914. Epub 2012 Mar 28.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
Nat Med. 2012 Jun;18(6):883-91. doi: 10.1038/nm.2753.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation.
J Proteomics. 2012 Dec 5;76 Spec No.:203-10. doi: 10.1016/j.jprot.2012.05.031. Epub 2012 Jun 2.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages.
J Immunol. 2012 Jul 15;189(2):744-54. doi: 10.4049/jimmunol.1102244. Epub 2012 Jun 18.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4.
Electrophoresis. 2012 Jul;33(12):1873-80. doi: 10.1002/elps.201100687.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Proteomics. 2012 Jul;12(13):2203-11. doi: 10.1002/pmic.201100376.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Proteomics. 2012 Jul;12(13):2203-11. doi: 10.1002/pmic.201100376.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles.
PLoS One. 2012;7(7):e42064. doi: 10.1371/journal.pone.0042064. Epub 2012 Jul 27.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome.
Int J Proteomics. 2012;2012:971907. doi: 10.1155/2012/971907. Epub 2012 Jul 18.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells.
Proteomics. 2013 Apr;13(7):1108-20. doi: 10.1002/pmic.201200531.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions.
Proteomics. 2013 Jul;13(14):2125-34. doi: 10.1002/pmic.201200323.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic characterization of human platelet-derived microparticles.
Anal Chim Acta. 2013 May 7;776:57-63. doi: 10.1016/j.aca.2013.03.023. Epub 2013 Mar 19.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties.
Mol Cell Proteomics. 2013 Aug;12(8):2205-19. doi: 10.1074/mcp.M113.028589. Epub 2013 May 8.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system.
Cell Host Microbe. 2013 May 15;13(5):521-34. doi: 10.1016/j.chom.2013.04.009.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Modulation of B-cell exosome proteins by gamma herpesvirus infection.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Characterization of human thymic exosomes.
PLoS One. 2013 Jul 2;8(7):e67554. doi: 10.1371/journal.pone.0067554. Print 2013.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18396. eCollection 2012.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.
PLoS One. 2013 Sep 19;8(9):e75054. doi: 10.1371/journal.pone.0075054. eCollection 2013.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration.
J Proteome Res. 2014 Feb 7;13(2):581-95. doi: 10.1021/pr400751k. Epub 2014 Jan 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative proteomics of extracellular vesicles released from human monocyte-derived macrophages upon beta-glucan stimulation.
J Proteome Res. 2014 May 2;13(5):2468-77. doi: 10.1021/pr4012552. Epub 2014 Apr 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Human urinary exosomes as innate immune effectors.
J Am Soc Nephrol. 2014 Sep;25(9):2017-27. doi: 10.1681/ASN.2013101066. Epub 2014 Apr 3.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.
J Alzheimers Dis. 2014;40 Suppl 1:S47-70. doi: 10.3233/JAD-132135.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors.
Proteomics. 2014 Jun;14(12):1494-502. doi: 10.1002/pmic.201300554. Epub 2014 May 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors.
Proteomics. 2014 Jun;14(12):1494-502. doi: 10.1002/pmic.201300554. Epub 2014 May 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein.
J Biol Chem. 2014 Aug 8;289(32):22284-305. doi: 10.1074/jbc.M114.549659. Epub 2014 Jun 17.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein.
J Biol Chem. 2014 Aug 8;289(32):22284-305. doi: 10.1074/jbc.M114.549659. Epub 2014 Jun 17.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein.
J Biol Chem. 2014 Aug 8;289(32):22284-305. doi: 10.1074/jbc.M114.549659. Epub 2014 Jun 17.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein.
J Biol Chem. 2014 Aug 8;289(32):22284-305. doi: 10.1074/jbc.M114.549659. Epub 2014 Jun 17.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Pathologic Mechanical Stress and Endotoxin Exposure Increases Lung Endothelial Microparticle Shedding.
Am J Respir Cell Mol Biol. 2014 Jul 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Pathologic Mechanical Stress and Endotoxin Exposure Increases Lung Endothelial Microparticle Shedding.
Am J Respir Cell Mol Biol. 2014 Jul 16.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro.
Biochim Biophys Acta. 2014 Nov;1838(11):2954-65. doi: 10.1016/j.bbamem.2014.07.026. Epub 2014 Aug 4.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration.
Front Pharmacol. 2014 Aug 11;5:175. doi: 10.3389/fphar.2014.00175. eCollection 2014.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration.
Front Pharmacol. 2014 Aug 11;5:175. doi: 10.3389/fphar.2014.00175. eCollection 2014.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes.
Sci Rep. 2014 Aug 29;4:6232. doi: 10.1038/srep06232.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
COG0480500 / 51 / 449
Elongation factor 2 (EF-2)P13639Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia.
Clin Proteomics. 2014 Nov 19;11(1):40. eCollection 2014.
COG0480500 / 51 / 449
[1] [2] [3] [4]